tallózása szerző szerint "Szalay, Balázs"

1-13 / 13

Circulating periostin level in asthmatic pregnancy

Ivancsó, István; Bohács, Anikó; Szalay, Balázs; Toldi, Gergely; Szilasi, Magdolna Emma; Müller, Veronika; Losonczy, György; Rigó, János; Vásárhelyi, Barna; Tamási, Lilla (2016)

OBJECTIVE: Asthma often complicates pregnancy and represents a risk for complications. Periostin is considered as a biomarker of asthma; however, as it also plays a role in normal gestation, pregnancy may influence circulating ...
Dexamethasone protects from renal ischemia/reperfusion injury: a possible association with SGK-1.

Rusai, Krisztina; Prókai, Ágnes; Juanxing C; Mészáros, Krisztina; Szalay, Balázs; Pásti, Krisztina; Müller, Veronika; Heemann U; Lutz J; Tulassay, Tivadar; Szabó, Attila (2013)

Previous experimental data suggest that steroids might have protective effects during hypoxic/ischemic injury of various organs. In this study, the association between dexamethason (Dexa) treatment and the anti-apoptotic ...
Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

Gönczi, Lóránt; Kürti, Zsuzsanna; Rutka, Mariann; Végh, Zsuzsanna; Farkas, Klaudia; Lovász, Barbara Dorottya; Golovics, Petra Anna; Gecse, Krisztina; Szalay, Balázs; Molnár, Tamás; Lakatos, Péter László (2017)
Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective, multicentre, nationwide cohort

Gecse, Krisztina; Lovász, Barbara Dorottya; Farkas, Klaudia; Banai J; Bene L; Gasztonyi, Beáta; Golovics, Petra Anna; Kristóf T; Lakatos, László; Csontos, Ágnes Anna; Juhász, Márk; Nagy, Ferenc; Palatka, Károly; Papp, Mária; Patai, Árpád; Lakner L; Salamon A; Szamosi T; Szepes, Zoltán; Tóth GT; Vincze, Áron; Szalay, Balázs; Molnár, Tamás; Lakatos, Péter László (2016)

Background and Aims: Biosimilar infliximab CT-P13 is approved for all indications of the originator product in Europe. Prospective data on its efficacy, safety, and immunogenicity in inflammatory bowel diseases are ...
Immune phenotype in children with therapy-naïve remitted and relapsed Crohn’s disease

Cseh, Áron; Vásárhelyi, Barna; Molnár, Kriszta; Szalay, Balázs; Svec, Peter; Treszl, András; Dezsőfi, Antal; Lakatos, Péter László; Arató, András; Tulassay, Tivadar; Veres, Gábor (2010)

AIM To characterize the prevalence of subpopulations of CD4+ cells along with that of major inhibitor or stimulator cell types in therapy naive childhood Crohn s disease (CD) and to test whether abnormalities of ...
Immunfenotípus és rövid távú T- limfocita aktiváció spondilitisz ankilopoetikában és reumatoid artritiszben

Szalay, Balázs (2016)
Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis

Legány, Nóra; Toldi, Gergely; Distler JH; Beyer C; Szalay, Balázs; Kovács, László; Vásárhelyi, Barna; Balog, Attila (2015)
Lymphocyte subsets in pediatric migraine

Cseh, Áron; Farkas, Márk Kristóf; Derzbach, László; Müller, Katalin Eszter; Vásárhelyi, Barna; Szalay, Balázs; Farkas, Viktor (2013)

Aseptic inflammation due to activated immune cells has been implicated in the pathomechanism of migraine. We measured the prevalence of regulatory T cells (Tregs), along with that of CD4(+)/CD8(+) lymphocytes and their ...
Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis

Toldi, Gergely; Szalay, Balázs; Bekő, Gabriella; Kovács, László; Vásárhelyi, Barna; Balog, Attila (2013)
T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy

Dulic S; Vasarhelyi Z; Sava, Florentina; Berta, László Gergely; Szalay, Balázs; Toldi, Gergely; Kovács, László; Balog, Attila (2017)

Data on the impact of biological therapies on the T-cell phenotype in rheumatoid arthritis are limited. Here, we prospectively measured the percentages of 15 circulating T-cell subtypes using flow cytometry. We obtained ...
The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.

Szalay, Balázs; Vásárhelyi, Barna; Cseh, Áron; Tulassay, Tivadar; Deák, Magdolna; Kovács, László; Balog, Attila (2014)

Rheumatoid arthritis (RA) is an autoimmune disease characterized by abnormal prevalence of Th1, Th2, Th17, and regulatory (Treg) subsets. Some data suggest that these subsets are influenced by anti-RA agents. Follow-up ...
The impact of DMARD and anti-TNF therapy on functional characterization of short-term T-cell activation in patients with rheumatoid arthritis - A follow-up study

Szalay, Balázs; Cseh, Áron; Mészáros, Gergő; Kovács, László; Balog, Attila; Vásárhelyi, Barna (2014)

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by a systemic dysfunction of T-cells. In this study we tested the impact of DMARD and anti-TNF agents on short-term activation characteristics of ...
Vitamin D deficiency is associated with impaired disease control in asthma-COPD overlap syndrome patients

Odler, Balázs; Ivancsó, István; Somogyi, V; Benke, Kálmán; Tamási, Lilla; Gálffy, Gabriella; Szalay, Balázs; Müller, Veronika (2015)

INTRODUCTION: The association between vitamin D and clinical parameters in obstructive lung diseases (OLDs), including COPD and bronchial asthma, was previously investigated. As asthma-COPD overlap syndrome (ACOS) is a new ...

1-13 / 13

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Szalay, Balázs"

DSpace/Manakin Repository

tallózása szerző szerint "Szalay, Balázs"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem